Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Dec:92:105926.
doi: 10.1016/j.msard.2024.105926. Epub 2024 Oct 11.

Long-term follow-up MR imaging in children with transverse myelitis

Affiliations
Multicenter Study

Long-term follow-up MR imaging in children with transverse myelitis

Ines El Naggar et al. Mult Scler Relat Disord. 2024 Dec.

Abstract

Background: We recently described magnetic resonance imaging (MRI) features of children with transverse myelitis (TM) at first event with important and unique differences depending on the underlying disease entity.

Objective: To study the resolution of lesions over time in children with TM due to MOG-antibody associated disorders (MOGAD), multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD) or double seronegative TM.

Patients and methods: In this prospective study, 78 children from 29 different medical centres with TM as part of MOGAD (n = 34), MS (n = 20), NMOSD (n = 5) and in double seronegative children (n = 19) were included. A grading system consisting of 4 grades (grade 0 = complete resolution; grade 3 = no resolution at all) was used to compare the degree of lesion resolution over time in the different disease entities. Time to lesion resolution was evaluated by Kaplan-Meier statistics and log-rank test.

Results: Significant differences of the interval between first MRI until resolution of lesions were observed between the four disease entities. The most rapid and complete resolution was seen in MOGAD, followed by double seronegative, MS and NMOSD. Median periods until total resolution (grade 0) were 191 days (MOGAD), 750 days (double seronegative), 1117 days (MS), while none of the patients with NMOSD reached a complete resolution during the observation period. The better prognosis of MOGAD compared to MS was independent of sex, age, oligoclonal bands and cell count in the multivariate Cox analysis (P < 0.001).

Conclusion: Children with TM and antibodies to MOG show a faster resolution of radiological lesions compared to children with MS and NMOSD.

Keywords: Acquired demyelinating syndrome; MOG; MRI; Neuroinflammation; Pediatric; Radiologic; Transverse myelitis.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Ines El Naggar: received travel grants from UCB. Eva-Maria Wendel: received travel grants from UCB. Annikki Bertolini: received travel grants from UCB. Markus Reindl: was supported by research grants from the Austrian Science Fund (FWF projects P32699 and IPN170), the Austrian Research Promotion Agency and Roche. Deiva Kumaran: received honoraria for invited talks for Biogen, Alexion, Sanofi and serves as consultant for Novartis and Horizon. Rinze Neuteboom: participated in pharmacological studies in demyelinating disorders with Roche, Horizon, Novartis and Sanofi-Genzym. Funding from Dutcht MS research foundation, Dreams Foundation, Postcode Loterij, Vrienden Sophia Foundation. Kevin Rostásy: received honoraria for invited talks from Horizon, UCB and serves as a consultant in the OperettaII study. Robert Cleaveland, Andreas Panzer, Sandy Molenaar, Laetitia Giorgi, Michael Karenfort, Charlotte Thiels, Zuzana Libá, Matthias Baumann, Steffen Leiz, Adela Della Marina, Jan G. Hengstler, members of the BIOMARKER study group (Steffen Berweck, Astrid Blaschek, Matthias Eckenweiler, Astrid Eisenkölbl, Tobias Geis, Annette Hackenberg, Verena Kraus, Heinz Lauffner, Daniela Pohl, Martin Pritsch, Michela Salandin, Torsten Sandrieser, Mareike Schimmel, Christoph von Kleist-Retzow, Gert Wiegand): no conflict of interest

Publication types

LinkOut - more resources